These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 33068247)

  • 1. Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.
    Slivnick JA; Wallner AL; Vallakati A; Truong VT; Mazur W; Elamin MB; Tong MS; Raman SV; Zareba KM
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1043-1051. PubMed ID: 33068247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
    Singulane C; Sun D; Hu Z; Lee L; Sarswat N; Emami Neyestanak M; Patel AR; Lang RM; Addetia K
    Curr Probl Cardiol; 2024 Sep; 49(9):102729. PubMed ID: 38945183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
    Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
    Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic features and rhythm disorders in cardiac amyloidosis.
    Martini N; Sinigiani G; De Michieli L; Mussinelli R; Perazzolo Marra M; Iliceto S; Zorzi A; Perlini S; Corrado D; Cipriani A
    Trends Cardiovasc Med; 2024 May; 34(4):257-264. PubMed ID: 36841466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
    Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
    J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of left ventricular trabeculae fractal analysis in patients with dilated cardiomyopathy.
    Xie WH; Chen BH; An DA; Wu R; Shi RY; Zhou Y; Cui HF; Zhao L; Wu LM
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101005. PubMed ID: 38302000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.
    Leyva F; Foley PW; Chalil S; Ratib K; Smith RE; Prinzen F; Auricchio A
    J Cardiovasc Magn Reson; 2011 Jun; 13(1):29. PubMed ID: 21668964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy.
    Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K
    Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
    Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
    Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Left Ventricular Activations Associated With ECG Pattern in Heart Failure Patients.
    Derval N; Duchateau J; Mahida S; Eschalier R; Sacher F; Lumens J; Cochet H; Denis A; Pillois X; Yamashita S; Komatsu Y; Ploux S; Amraoui S; Zemmoura A; Ritter P; Hocini M; Haissaguerre M; Jaïs P; Bordachar P
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28630171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Left Ventricular
    Clerc OF; Datar Y; Cuddy SAM; Bianchi G; Taylor A; Benz DC; Robertson M; Kijewski MF; Jerosch-Herold M; Kwong RY; Ruberg FL; Liao R; Di Carli MF; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2024 Aug; 17(8):911-922. PubMed ID: 39001731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy.
    Khurshid S; Liang JJ; Owens A; Lin D; Schaller R; Epstein AE; Marchlinski FE; Frankel DS
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1174-1179. PubMed ID: 27457998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.